BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20655603)

  • 1. Peptide drugs to target G protein-coupled receptors.
    Bellmann-Sickert K; Beck-Sickinger AG
    Trends Pharmacol Sci; 2010 Sep; 31(9):434-41. PubMed ID: 20655603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine receptors as targets for new drugs.
    Altman J
    Neuroendocrinology; 2006; 83(5-6):282-8. PubMed ID: 16926529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in strategies to improve drug delivery to brain tumors.
    Newton HB
    Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors.
    Romagne F
    Drug Discov Today; 2007 Jan; 12(1-2):80-7. PubMed ID: 17198976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering and improving novel peptide therapeutics.
    McGregor DP
    Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical studies of peptide receptor radionuclide therapy.
    Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
    Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E; Zampeli E; Sander K; Stark H
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-specific delivery of a chemotherapeutic to lung cancer cells.
    Zhou X; Chang YC; Oyama T; McGuire MJ; Brown KC
    J Am Chem Soc; 2004 Dec; 126(48):15656-7. PubMed ID: 15571383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.
    Hoare SR
    Drug Discov Today; 2005 Mar; 10(6):417-27. PubMed ID: 15808821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic therapeutic peptides: science and market.
    Vlieghe P; Lisowski V; Martinez J; Khrestchatisky M
    Drug Discov Today; 2010 Jan; 15(1-2):40-56. PubMed ID: 19879957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical delivery of peptides: applicability for cancer therapy.
    Dass CR; Choong PF
    Peptides; 2006 Dec; 27(12):3479-88. PubMed ID: 16996648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promiscuous drugs as therapeutics for chemokine receptors.
    Horuk R
    Expert Rev Mol Med; 2009 Jan; 11():e1. PubMed ID: 19123963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic cancer targeting peptides.
    Aina OH; Sroka TC; Chen ML; Lam KS
    Biopolymers; 2002; 66(3):184-99. PubMed ID: 12385037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin targeted drug and gene delivery.
    Wang Z; Chui WK; Ho PC
    Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions for peptide therapeutics development.
    Kaspar AA; Reichert JM
    Drug Discov Today; 2013 Sep; 18(17-18):807-17. PubMed ID: 23726889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.